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EARLY RESEARCH with anti-lymphocyte serum (1-6) involved the use 
of inbred rats, mice, or guinea pigs. The  development of a safe horse- 
anti-dog lymphocyte serum to be described has gone through 3 stages. 
In the first stage, anti-lymphocyte plasma (ALP) was prepared by 
subcutaneously injecting 4 to 20 million dog lymph node lymphocytes 
into 6 horses from 4 to 12 times at intervals of 1 to 8 weeks. The  
heparinized plasma was heated at 56" C. for 30 min. Leuko-agglutinin 
titers of the horse plasma against dog white cells rose from control to 
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1 : 16 to 1 : 128; lympho-agglutinin titers spot checked were essentially 
the same as with unseparated dog white cells. T h e  resulting pooled 
ALP, which caused marked lymphopenia, was toxic. Of 36 dogs to 
which i t  was given I P  (1 to 4 ml./kg./day), 11 died within 15 days. 
Anaphylactic reactions were common. Anemia was invariable; 26 dogs 
studied for 15 days had a hematocrit value fall from 40.1 f. 4.1 (SD)% 
to 30.8 2 6.3 (SD)yo. The  25 remaining dogs, subjected to bilateral 
nephrectomy and renal homotransplantation from nonrelated donors, 
subsequently lived 4 to 144 days (mean 32.3 -1- 33.3 (SD) days); 10 
lived longer than a month. Twelve of the 25 dogs which had received 
thymectomy in advance did not fare better than the other 13. The  
ALP was thus markedly immunosuppressive but excessively danger- 
ous. 
In the second stage, anti-lymphocyte serum (ALS) was prepared 
from the same horses. Heteroagglutinins were partially absorbed with 
1 part dog red cell pack against 10 parts ALS. This product given I P  
was also lymphopenic, but it did not cause any deaths among 19 dogs 
treated daily for 16 to 22 days. However, in 19 dogs the fall in hemato- 
crit value during 15 days was from 45.8 + 4.4 (SD)yo to 34 + 5 (SD)%. 
Six dogs pretreated for 16 to 18 days were then provided with renal 
homografts. Survival was 13 to 49 days 27.2 + 13 (SD) days), 2 of 
the 6 living more than a month. Nine more pretreated animals were 
given orthotopic liver transplants. The  present mean survival is 
22.9 t 20.4 (SD) days; 2 dogs are still alive after 37 and 68 days. One 
of the latter dogs was only treated preoperatively. T h e  other (the long- 
est survivor) had therapy stopped 3 weeks after operation with no 
subsequent deterioration. Both now have marked lymphocytosis. T h e  
effect of ALS tends to be lasting and is not dependent on continued 
lymphopenia. Finally, 6 dogs had renal homotransplantation without 
pretreatment. Survival was 12.8 2 12.5 (SD) days. Only 1 dog lived 
more than 12 days. Pretreatment is therefore an important factor. 
The  features of rejection in the homografted organs did not differ 
from those seen after prolongation of survival with agents such as 
azathioprine. Dogs who received either ALS or ALP with or without 
transplantation had depletion of the small lymphocytes in all lymph- 
oid depots. In  transplanted dogs, pyroninophilic cells were present in 
varying numbers and many were in mitosis. Nontransplanted dogs 
receiving ALS or ALP intraperitoneally did not have injury of their 
kidneys but all had received treatment for 14 days or less. In  10 other 
dogs given 2 to 6 ml. ALS/kg. IV for 18 days to 2 months in a toxicity 
study, subepithelial deposits were present on the renal glomerular 
capillary basement membrane in 6. 
In the third stage, the immunizing doses of white cells were dras- 
tically increased by giving 5 to 95 billion spleen white cells to each 
horse 1 to 3 times a week for 4 weeks. Leuko-agglutinin titers rose to 
as high as 1 : 32,000. In an additional horse, similar immunization with 
human spleen resulted in a comparable anti-human lymphocyte re- 
sponse. The ALS was repeatedly absorbed with 10yo to 30% of dog 
red cells and in some cases also with 5% serum, 10% to 25y0 kidney, 
and 10% to 25y0 liver. Red cell and serum absorption caused little 
titer loss but 75y0 to 95% was lost with liver and kidney. The ab- 
sorbed serum was precipitated first with 0.35 and then with 0.5 sat 
NH,SO,; most of the activity was in the 0.35 portion. The 0.35 portion 
was lyophilized, reconstituted, and tested, or alternatively passed 
through a diethylaminoethanol cellulose column. With column 
separation, 2 principal fractions were collected, neither completely 
pure. The first (principally globulin G) contained a high leuko- 
agglutinin titer. The second, which had a low titer, was principally 
globulin M. The active principle is probably an immunoglobulin G 
(7s). 
' iymphopenia was caused by all the altered products providing a 
sufficient SC dose was used. Anemia did not occur; anaphylactic re- 
action has not been seen in any of 24 test dogs. The acute risk with the 
material absorbed only with red blood cells and serum was not greater 
than with that also absorbed with kidney and liver. Using small doses 
of 0.35 saturated precipitated material which did not cause lympho- 
penia, immunosuppression was evident under certain circumstances. 
Six dogs, which had therapy started the day before operation, sur- 
vived only 4 to 13 days after renal homotransplantation. In contrast, 
3 of 4 dogs which received orthotopic liver transplants with the same 
therapy are well after 16 to 21 days. Six more dogs received renal 
homografts with the same dose, started 12 days preoperatively, and 
continued postoperatively. Four died after 9 to 13 days but the other 
2 are still alive. These findings confirm the value of pretreatment cited 
earlier, prove that peripheral lyrnphopenia is not a prerequisite to 
success, and suggest that it is fundamentally easier to prevent repudi- 
ation of the liver than of the kidney. 
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